albuterol sulfate 108 MCG/ACTUAT / budesonide 80 MCG/ACTUAT Metered Dose Inhaler, 28 Actuations

RxCUI
2678391
RxNorm name
albuterol sulfate 108 MCG/ACTUAT / budesonide 80 MCG/ACTUAT Metered Dose Inhaler, 28 Actuations
Display name
albuterol sulfate 108 MCG/ACTUAT / budesonide 80 MCG/ACTUAT Metered Dose Inhaler, 28 Actuations
Full name
albuterol sulfate 108 MCG/ACTUAT / budesonide 80 MCG/ACTUAT Metered Dose Inhaler, 28 Actuations
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AIRSUPRAALBUTEROL SULFATE AND BUDESONIDEAstraZeneca Pharmaceuticals LPe60aa9f9-5139-44df-b886-ebddc3c7eb132025-09-18Warnings, Adverse reactionsExact identifier
rxcui: 2678391

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e60aa9f9-5139-44df-b886-ebddc3c7eb13albuterol 90 MCG/INHAL / budesonide 80 MCG/INHAL Metered Dose Inhaler, 28 Actuations [PSN] · 28 ACTUAT albuterol 0.09 MG/ACTUAT / budesonide 0.08 MG/ACTUAT Metered Dose Inhaler [SCD] · albuterol sulfate 108 MCG/ACTUAT / budesonide 80 MCG/ACTUAT Metered Dose Inhaler, 28 Actuations [SY]310These highlights do not include all the information needed to use AIRSUPRA ® safely and effectively. See full prescribing information for AIRSUPRA. AIRSUPRA (albuterol and budesonide) inhalation aerosol, for oral inhalation use Initial U.S. Approval: 202320250918